Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice by Darya Ivashkevich, Arina Ponomarenko, Igor Manzhulo, Anastasia Egoraeva, Inessa Dyuizen

Subjects: Get full text

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and mortality in patients with metabolic dysfunction-associate... by Ying Zhang, Peng-Yu Luo, Yu-Na Tang, Jing Wang, Shuai Gao, Yu-Chen Fan, Kai Wang

Subjects: “…MASLD…”
Get full text

From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status by Andrea Boccatonda, Damiano D’Ardes, Veronica Moronti, Jessica Santilli, Alessia Cipollone, Gianfranco Lessiani, Nicoletta Di Gregorio, Carla Serra, Fabio Piscaglia, Claudio Ferri, Francesco Cipollone

Subjects: “…MASLD…”
Get full text

Influence of levothyroxine replacement on metabolic dysfunction-associated steatotic liver disease and dyslipidemia in subclinical hypothyroidism: insights from a randomized contro... by Zainab Gaber Mahran, Salma Mokhtar Osman, Amira Abdelmawgod, Nahed A. Makhlouf, Elham Ahmed Hassan, Ehab F. Moustafa

Subjects: Get full text

Consensus Statement on Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL‐TSPGHAN Expert Committee by Yu‐Cheng Lin, Fang‐Min Liao, Hsun‐Ching Chao, An‐Chyi Chen, Yung‐Ming Jeng, Chieh‐Chung Lin, Mao‐Meng Tiao, Yao‐Jong Yang, Chun‐Yan Yeung, Huey‐Ling Chen, Yen‐Hsuan Ni

Subjects: Get full text

Therapeutic intervention with anti-TNF alleviates colonic and hepatic toxicity induced by perfluorooctanoic acid (PFOA)Mendeley Data by Wei Li, Yongjing Qian, Xiaojing Cai, Yu He, Xiannan Meng, Ling Zhang

Subjects: Get full text

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults i... by Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed

Subjects: “…masld…”
Get full text

Significant Within-Individual Variability in VCTE Liver Stiffness Measurements at Two Intercostal Spaces in Subjects with MASLD: Implications for Evaluating Improvement in Liver Fi... by Jordan S. Woodard, Jena Velji-Ibrahim, Gary A. Abrams

Subjects: “…MASLD…”
Get full text

Serum uric acid trajectories and risk of metabolic dysfunction-associated steatotic liver disease in China: a 2019–2021 cohort health survey by Dan Shi, Qilong Tan, Yong Zhang, Xiaoya Qi, Xiaoyang Xu, Guoqiong Xu, Ruixue Bai, Jing Deng, Mengxue Chen, Tao Jiang, Ying Mei

Subjects: “…MASLD…”
Get full text

Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis by Linjing Long, Yue Wu, Huijun Tang, Yanhua Xiao, Min Wang, Lianli Shen, Ying Shi, Shufen Feng, Chujing Li, Jiaheng Lin, Shaohui Tang, Chutian Wu

Subjects: “…MASLD…”
Get full text

Protein restriction associated with high fat induces metabolic dysregulation without obesity in juvenile mice by Amélie Joly, Jean-Louis Thoumas, Anne Lambert, Estelle Caillon, François Leulier, Filipe De Vadder

Subjects: Get full text

Association between dietary acid load and risk of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes by Hesam Bakhshi, Niayesh Naghshi, Danial Fotros, Mohammadjavad Pasand, Azita Hekmatdoost, Marieh Salavatizadeh, Samira Soltanieh, Hossein Poustchi, Mohammad Ebrahim Khamseh, Zahra Yari

Subjects: “…MASLD…”
Get full text

Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues by Clara Meda, Arianna Dolce, Sara Della Torre

Subjects: “…masld…”
Get full text

<i>Faecalibacterium prausnitzii</i> Is Associated with Disease Severity in MASLD but Its Supplementation Does Not Improve Diet-Induced Steatohepatitis in Mice by Eliane Münte, Greta Viebahn, Amit Khurana, Jumpei Fujiki, Tomohiro Nakamura, Sonja Lang, Münevver Demir, Bernd Schnabl, Phillipp Hartmann

Subjects: Get full text

Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus by Hilmi Erdem Sümbül, Tayyibe Saler, Ahmet Gazi Mustan, Cahit Dincer, İrfan Alişan, Bercem Berent Kaya, Mehmet Can Erişen, Bektaş Işık, Begüm Şeyda Avci, Fatih Necip Arici, Dilan Damla Ozturk, Erdinc Gulumsek, Hüseyin Ali Öztürk

Subjects: Get full text

Circulating Asprosin and Neuregulin-4 in metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis by Roshan Kumar Mahat, Vedika Rathore

Subjects: Get full text

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes by Mohamad Suki, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Yariv Tiram, Ofer Perzon, Yousra Sharif, Joseph Sackran, Revital Alon, Nachum Emil Eliezer Lourie, Itamar Raz, Ashraf Imam, Abed Khalaileh, Rifaat Safadi

Subjects: Get full text

New Insights into the Interplay Between Simple Sugars and Liver Diseases by Simona Parisse, Erika Coltorti, Monica Mischitelli, Flaminia Ferri, Stefano Ginanni Corradini

Subjects: Get full text

Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD by Ahmad Moolla, Toryn Poolman, Nantia Othonos, Jiawen Dong, Kieran Smith, Thomas Cornfield, Sarah White, David W. Ray, Sofia Mouchti, Ferenc E. Mózes, Helena Thomaides-Brears, Stefan Neubauer, Jeremy F. Cobbold, Leanne Hodson, Jeremy W. Tomlinson

Subjects: “…MASLD…”
Get full text

Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue by Alvile Kasarinaite, Maria Jimenez Ramos, Mariana Beltran-Sierra, Elena F. Sutherland, Pedro Arede Rei, Make Zhao, Ying Chi, Meryam Beniazza, Andrea Corsinotti, Timothy J. Kendall, Neil C. Henderson, Jonathan A. Fallowfield, Philippa T. K. Saunders, David C. Hay

Subjects: Get full text